
Merit Medical Systems, Inc.
MMSINASDAQHealthcareMedical - Instruments & Supplies
Latest quote
$90.74
+$0.51 · +0.56%
MMSI company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Buy
Favorable setup — positive multi-factor alignment
Valuation
80
Undervalued
Momentum
47
Neutral
Sentiment
74
Bullish
Risk resilience
70
Moderate Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteMerit Medical Systems, Inc. (MMSI) is engaged in the design, development, manufacturing, and worldwide commercialization of disposable medical products. These devices are crucial for a broad spectrum of diagnostic, therapeutic, and interventional procedures, primarily within the fields of cardiology, radiology, oncology, critical care, and endoscopy. The company operates through two main divisions: Cardiovascular and Endoscopy. Its extensive product portfolio includes advanced solutions for diagnosing and treating conditions in peripheral vessels and organs, as well as a comprehensive suite of cardiac intervention products. The latter encompasses tools for vascular access, angiography, electrophysiology, cardiac rhythm management, fluid and hemodynamic monitoring, hemostasis, and various interventional therapies for heart-related ailments. Additionally, MMSI provides customized procedural solutions, offering critical care items, disinfection protection systems, specialized syringes, manifold kits, and tailored trays and packs. Their offerings further extend to coated tubes and wires, alongside sophisticated sensor components for microelectromechanical systems (MEMS). The company also features pulmonary products, such as laser-cut tracheobronchial stents with their accompanying over-the-wire and direct visualization delivery systems, and dilation balloons used for endoscopic stricture dilation. Gastroenterology products, as well as essential kits and accessories for endoscopy and bronchoscopy procedures, complete their diverse catalog. Merit Medical Systems sells its products to a wide client base, including hospitals and healthcare professionals (physicians, technicians, and nurses) working in alternative care settings. Distribution channels include a direct sales force, authorized distributors, original equipment manufacturer (OEM) partnerships, and custom procedure tray manufacturers, reaching customers throughout the United States and internationally. Founded in 1987, Merit Medical Systems, Inc. has its corporate headquarters situated in South Jordan, Utah.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Martha Goldberg Aronson
- Listed since
- May 14, 1990
- Employees
- 7,500
Market position
- Volume
- 401.8K
- 0.46× average
- Average volume
- 879.97K
- Average daily volume
- Market cap
- 5.42B USD
- Beta
- 0.48
- Market reference 1
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 5.66B USD
- P/E (TTM)
- 37.05×
- P/B (TTM)
- 3.23×
- P/S (TTM)
- 3.43×
- EV / EBITDA
- 17.06×
- Earnings yield
- 2.46%
- Free cash flow yield
- 4.08%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 49.52%
- Operating margin
- 12.75%
- Net margin
- 9.22%
- Return on equity
- 8.11%
- Return on assets
- 4.78%
- Return on invested capital
- 5.64%
Financial health
- Debt / equity
- 0.49×
- Current ratio
- 4.34×
- Altman Z-score
- 4.36
- Piotroski F-score
- 6 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.51B USD | 1.36B USD | 1.26B USD | 1.15B USD | 1.07B USD |
| Cost of goods sold | 777.79M USD | 713.18M USD | 673.49M USD | 631.88M USD | 589.42M USD |
| Gross profit | 736.94M USD | 643.33M USD | 583.87M USD | 519.1M USD | 485.33M USD |
| Research and development | 97.35M USD | 83.81M USD | 82.73M USD | 75.51M USD | 71.25M USD |
| Selling, general, and administrative | 455.21M USD | 376.73M USD | 373.68M USD | 342.53M USD | 335.69M USD |
| Operating expenses | 552.57M USD | 487.64M USD | 458.73M USD | 431.54M USD | 424.42M USD |
| Interest income | 15.07M USD | 26.23M USD | 2.46M USD | 439K USD | 769K USD |
| Interest expense | 26.46M USD | 31.22M USD | 15.51M USD | 6.34M USD | 5.26M USD |
| Depreciation and amortization | 134.65M USD | 114.73M USD | 101.29M USD | 92.2M USD | 95.78M USD |
| Operating income | 184.38M USD | 155.69M USD | 123.94M USD | 87.56M USD | 60.92M USD |
| Net income | 128.49M USD | 120.36M USD | 94.41M USD | 74.52M USD | 48.45M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 100%
- 11 beats, 0 misses, 0 met estimates
- Average EPS surprise
- +11.63%
- 11 comparable reports
- Latest EPS result
- 1.19
- Estimate 0.96 · Beat by 24.09%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$99.22
9.30% upsideRating distribution
15 ratingsMMSI news
Corporate actions
Corporate action history
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | May 6, 2011 | 5:4 | — | — |
Stock split | Dec 3, 2003 | 4:3 | — | — |
Stock split | Aug 15, 2003 | 4:3 | — | — |
Stock split | Apr 12, 2002 | 5:4 | — | — |
Stock split | Aug 28, 2001 | 5:4 | — | — |
Stock split | Jul 16, 1991 | 3:2 | — | — |
Effective May 6, 2011
5:4
Effective Dec 3, 2003
4:3
Effective Aug 15, 2003
4:3
Effective Apr 12, 2002
5:4
Effective Aug 28, 2001
5:4
Effective Jul 16, 1991
3:2
MMSI peers
ETFs holding MMSI
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core S&P Small-Cap ETFIJR325.83M0.29%111.19B USD0.06%$147.31+0.64%
Vanguard Morningstar Total Stock Market ETFVTI153.92M0.01%2.3T USD0.03%$378.24+0.44%
iShares Russell 2000 ETFIWM138.28M0.17%81.62B USD0.19%$299.96+0.77%
Vanguard Morningstar Small-Cap ETFVB110.79M0.06%183.4B USD0.03%$304.76+0.64%
Vanguard Morningstar Small-Cap Growth ETFVBK63.97M0.14%43.8B USD0.05%$358.65+0.70%
Vanguard Extended Market ETFVXF58.42M0.06%93.7B USD0.05%$245.53+0.82%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM50.97M0.30%17.03B USD0.03%$57.28+0.61%
iShares Russell 2000 Value ETFIWN45.39M0.31%14.66B USD0.24%$224.81+0.45%
iShares Core S&P Small-Cap ETFIJR- Market value
- 325.83M
- Weight
- 0.29%
- AUM
- 111.19B USD
- Expense ratio
- 0.06%
- Price / 1D
- $147.31+0.64%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 153.92M
- Weight
- 0.01%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
iShares Russell 2000 ETFIWM- Market value
- 138.28M
- Weight
- 0.17%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Vanguard Morningstar Small-Cap ETFVB- Market value
- 110.79M
- Weight
- 0.06%
- AUM
- 183.4B USD
- Expense ratio
- 0.03%
- Price / 1D
- $304.76+0.64%
Vanguard Morningstar Small-Cap Growth ETFVBK- Market value
- 63.97M
- Weight
- 0.14%
- AUM
- 43.8B USD
- Expense ratio
- 0.05%
- Price / 1D
- $358.65+0.70%
Vanguard Extended Market ETFVXF- Market value
- 58.42M
- Weight
- 0.06%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM- Market value
- 50.97M
- Weight
- 0.30%
- AUM
- 17.03B USD
- Expense ratio
- 0.03%
- Price / 1D
- $57.28+0.61%
iShares Russell 2000 Value ETFIWN- Market value
- 45.39M
- Weight
- 0.31%
- AUM
- 14.66B USD
- Expense ratio
- 0.24%
- Price / 1D
- $224.81+0.45%
Continue in GoAI
Research MMSIresearch.disclaimer











